je.st
news
Tag: clinical
Clinical Workflow Software enables evidence-based admissions.
2015-03-26 13:31:07| Industrial Newsroom - All News for Today
Using Indicia for Admission Support, hospitals can rapidly make and document evidence-based decisions about when to admit patients to observation or inpatient care. Program helps hospitals identify diagnoses presenting highest risk of short-stay audit, particularly for Medicare population. Articulating evidence-based rationale in medical record helps to mitigate short-stay denials. Additionally, solution facilitates efficient management of observation stays through to admission or discharge.
Tags: software
clinical
enables
workflow
Cartagenia Partners with N-of-One to Provide Pathology Laboratories and Cancer Centers Access to Clinical Interpretation Services
2015-03-23 11:31:17| Industrial Newsroom - All News for Today
Customers of Cartagenia's Bench Lab NGS software platform now have option to access N-of-One Clinical Interpretation uniquely specific to each patient's molecular profile BOSTON - Cartagenia, leader in providing clinical genetics and pathology labs with variant assessment reporting support software, today announced...
Tags: services
provide
access
partners
New Data Investigating Mercks KEYTRUDA (pembrolizumab) in Advanced Non-Small Cell Lung Cancer and Mesothelioma to Be Presented in Clinical Trials Plenary Session at AACR 2015
2015-03-18 21:19:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Data to be Presented Across Multiple Tumor Types for KEYTRUDA and MK-8628 (OTX015), an Investigational BET-Bromodomain Inhibitor KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data evaluating KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in both advanced non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma will be presented as part of the Clinical Trials Plenary Session on Sunday, April 19 at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia, April 18 22. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
advanced
presented
cell
Feasibility Study Software improves clinical project planning.
2015-03-13 13:31:06| Industrial Newsroom - All News for Today
Accelerating effective planning, FeRMI creates integrated, electronic approach for conducting clinical trial feasibility studies. Each process step is managed electronically; data collection from sites is completed via customizable online surveys with real-time error checks. While investigator database module hastens potential sites selection and tracks previous contacts and historical study performance, real-time reporting module helps users track trends and make site selection decisions.
Tags: software
project
study
planning
DATATRAK Challenges the Industry at Outsourcing in Clinical Trials Southeast
2015-03-05 11:31:17| Industrial Newsroom - All News for Today
Calls Clinical Research Professionals to Question their eClinical Solutions CLEVELAND DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced a challenge to the clinical...
Tags: industry
clinical
challenges
southeast
Sites : [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »